TGFb for Immuno-Oncology Drug Development Summit

The TGFb for Immuno-Oncology Drug Development Summit is dedicated to taming the TGFβ double-edged sword for tumor suppression.

The TGFb for Immuno-Oncology Drug Development Summit covers topics such as:

• Targeting TGF-ß through Integrin Inhibition: Small Molecule vs Antibody Approaches
• TGF-ß in Immuno-oncology Drug Development: Current State of Play
• Targeting with Anti-TGF-ß Traps
• Exploring Mechanism of Action and Biomarker Development
• Dissecting the Dual Relationships between CAR-T & TGF-ß
• Advancing Antibody Approaches
• Translating TGFß into the Clinic
• ATAC Platform & Antisense Agents

The TGFb for Immuno-Oncology Drug Development Summit will be held on 26-28 Jan 2021.